Weight Loss Drugs and Active Menopausal Women with Jody Dushay, MD (REBROADCAST)

Hit Play Not Pause

Health & Fitness, Education, Self-improvement, Mental Health

4.9 • 696 Ratings

🗓️ 7 August 2024

⏱️ 74 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

The New York Times recently called Ozempic a “new match for menopausal weight gain”. But is it? These drugs can be a godsend for those who need them. But there's a lot we need to understand. How do they work? How well do they work? Who benefits from them? What are their risks? What impact do they have on muscle, bone, and performance? How do they affect training and racing? We dig into all of that and more this week with endocrinologist and Ironman triathlete Dr. Jody Dushay who has been researching these drugs for more than a decade.

Jody Dushay, M.D., MMSc, is an endocrinologist at the Beth Israel Deaconess Medical Center and assistant professor of medicine at Harvard Medical School. She is also the founder and director of Well Powered, a comprehensive wellness and weight management program. Dr Dushay has studied the effect of pharmacotherapies and dietary interventions on body weight for years, including a large single-site study examining the effects of a glucagon-like peptide receptor agonist on body weight in obese women without diabetes. As a triathlete, she has qualified for Kona 3 times and came in 2nd in her age group at the 2020 Ironman World Championship in St George. You can learn more about her and her work at wellpowered.org.

Resources:

Dr. Jody Dushay’s research:

Short-term exenatide treatment leads to significant weight loss in a subset of obese women without diabetes

Weight Loss Outcomes Among Early High Responders to Exenatide Treatment: A Randomized, Placebo Controlled Study in Overweight and Obese Women

Enroll in our Navigate Menopause Course - https://www.feistymenopause.com/navigate-menopause

Subscribe to the Feisty 40+ newsletter: https://feistymedia.ac-page.com/feisty-40-sign-up-page

Feisty Menopause: @feistymenopause

Hit Play Not Pause Facebook Group: https://www.facebook.com/groups/807943973376099

Support our Partners:

Hettas: Use code FEISTY20 for 20% off at https://hettas.com/

Midi Health: You Deserve to Feel Great. Book your virtual visit today at https://www.joinmidi.com/

Nutrisense: Go to nutrisense.io/hitplay and use code: HITPLAY to get $125 off

Previnex: Get 15% off your first order with code HITPLAY at https://www.previnex.com/

Paradis Sport: Use code: FEISTY20 for 20% off any single item at https://paradissport.com/

This podcast uses the following third-party services for analysis:

Spotify Ad Analytics - https://www.spotify.com/us/legal/ad-analytics-privacy-policy/
Podcorn - https://podcorn.com/privacy
Podscribe - https://podscribe.com/privacy

Transcript

Click on a timestamp to play from that location

0:00.0	You are listening to Hit Play, Not Pause, a feisty menopause podcast for active performance-minded women.
0:14.6	I am your host, Celine Yeager. Each week, I bring you advice from athletes, scientists, researchers, and other experts to help you feel and perform you best, no matter what your hormones are doing.
0:25.0	This show is a production of Live Feisty Media.
0:31.2	Hello, strong feisty women.
0:34.3	Okay.
0:35.4	Everyone out there knows that weight loss is not one of my favorite topics, because we all grew up steeped in diet culture and harmful, idealized images of women who were stick-skinned and often unhealthy.
0:48.9	That said, I do recognize that body composition changes are a major concern for many menopausal women,
0:55.6	as we can see some pretty sudden shifts in muscle mass and body fat during this time.
1:00.8	And many women are now interested in the current weight loss injectable drugs known as
1:06.1	GLP1 receptor agonists, otherwise known as OZempic and Wagovi and others.
1:12.3	And that interest is only going to get stronger as menopausal women are increasingly being
1:17.9	marketed and targeted for these drugs. In fact, the New York Times recently published a feature
1:23.1	called OZempic, a new match for menopausal weight gain. But is it? How do these drugs work? How well do
1:30.9	they work? Who benefits from them? What are their risks? What impact do they have on muscle,
1:36.4	bone, and performance? These are important questions for active women, especially since they can
1:41.9	negatively impact some of that.
1:51.3	To get those answers, I reached out to endocrinologist and Ironman triathlete, Dr. Jody Doucher, who has been researching these drugs for more than a decade.
1:54.3	And to be clear, though there are some important pitfalls around these medications, they
1:59.2	can be a game changer for those who need them. We dig into
2:02.7	all of that during this conversation. Jody is an endocrinologist at the Beth Israel Deaconess Medical
2:09.1	Center and assistant professor of medicine at Harvard Medical School. She's also the founder and
2:14.6	director of Well-powered, a comprehensive wellness and weight management
	...

Transcript will be available on the free plan in -236 days. Upgrade to see the full transcript now.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Hit Play Not Pause, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Hit Play Not Pause and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.